Gene · 3702
Papers2,789
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,161 to 1,180 of 2,789
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Discovery of 5-Phenoxy-2-aminopyridine Derivatives as Potent and Selective Irreversible Inhibitors of Bruton's Tyrosine Kinase. | Int J Mol Sci | 2020 | 33126415 | PubTator, text mining | PubMed |
| Circulating T Cells Exhibit Different TIM3/Galectin-9 Expression in Patients with Obesity and Obesity-Related Diabetes. | J Diabetes Res | 2020 | 33123595 | PubTator, text mining | PubMed |
| OsteoBLAST: Computational Routine of Global Molecular Analysis Applied to Biomaterials Development. | Front Bioeng Biotechnol | 2020 | 33117780 | PubTator, text mining | PubMed |
| B Cells versus T Cells in the Tumor Microenvironment of Malignant Lymphomas. Are the Lymphocytes Playing the Roles of Muhammad Ali versus George Foreman in Zaire 1974? | J Clin Med | 2020 | 33114418 | PubTator, text mining | PubMed |
| Discovery of Tricyclic Pyranochromenone as Novel Bruton's Tyrosine Kinase Inhibitors with in Vivo Antirheumatic Activity. | Int J Mol Sci | 2020 | 33113810 | PubTator, text mining | PubMed |
| Deep neural network to locate and segment brain tumors outperformed the expert technicians who created the training data. | J Med Imaging (Bellingham) | 2020 | 33102623 | PubTator, text mining | PubMed |
| Efficacy and Safety of Stem Cell Therapy for T1DM: An Updated Systematic Review and Meta-Analysis. | J Diabetes Res | 2020 | 33102605 | PubTator, text mining | PubMed |
| A Methylation-Based Reclassification of Bladder Cancer Based on Immune Cell Genes. | Cancers (Basel) | 2020 | 33092083 | PubTator, text mining | PubMed |
| Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma. | Front Oncol | 2020 | 33072571 | PubTator, text mining | PubMed |
| History of hematopoietic cell transplantation: challenges and progress. | Haematologica | 2020 | 33054108 | PubTator, text mining | PubMed |
| Safety and efficacy of brentuximab vedotin as a treatment for lymphoproliferative disorders in primary immunodeficiencies. | Haematologica | 2020 | 33054064 | PubTator, text mining | PubMed |
| The Diverse Roles of TAO Kinases in Health and Diseases. | Int J Mol Sci | 2020 | 33050415 | PubTator, text mining | PubMed |
| T Cell Activation Machinery: Form and Function in Natural and Engineered Immune Receptors. | Int J Mol Sci | 2020 | 33050044 | PubTator, text mining | PubMed |
| Ibrutinib for chronic lymphocytic leukemia in the setting of respiratory failure from severe COVID-19 infection: Case report and literature review. | EJHaem | 2020 | 33043320 | PubTator, text mining | PubMed |
| Tumor Microenvironment-Associated Immune-Related Genes for the Prognosis of Malignant Pleural Mesothelioma. | Front Oncol | 2020 | 33042835 | PubTator, text mining | PubMed |
| Low-cost low-field NMR and MRI: Instrumentation and applications. | J Magn Reson | 2020 | 33036708 | PubTator, text mining | PubMed |
| Weighted Gene Co-expression Network Analysis of Key Biomarkers Associated With Bronchopulmonary Dysplasia. | Front Genet | 2020 | 33033495 | PubTator, text mining | PubMed |
| SUFU mediates EMT and Wnt/β-catenin signaling pathway activation promoted by miRNA-324-5p in human gastric cancer. | Cell Cycle | 2020 | 33017570 | PubTator, text mining | PubMed |
| Screening of key genes related to the prognosis of mouse sepsis. | Biosci Rep | 2020 | 33015708 | PubTator, text mining | PubMed |
| Somatic Mutation Profiling of Intrahepatic Cholangiocarcinoma: Comparison between Primary and Metastasis Tumor Tissues. | J Oncol | 2020 | 33014052 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3702/papers?page=59